Abstract
Progressive neurodegenerative diseases such as Alzheimer’s, Parkinson’s, Huntington’s disease, and amyotrophic lateral sclerosis affect millions of people around the world. In addition, these diseases cause emotional, medical, and financial burden on the caregivers and the society. Common symptoms of these patients in include depression, memory impairment, anxiety, and defective motor function. A major pathological signature of these diseases is the accumulation of aggregates of different proteins in different parts in the brain. Unfortunately, there is no cure yet; presently management options are available which provides some relief from the disease symptoms. Intense investigations are ongoing by independent research groups to develop an effective novel therapy to protect these helpless patients. Because misfolding of proteins is a common pathological marker, upregulation of protein chaperones in the affected area is being considered as a promising therapeutic approach to treat these diseases. Small molecules of natural origins of distinct mode of actions have been identified that modulate activity of different components of chaperone signaling pathway with a positive outcome in the animal models. In this book chapter, we provide an account on the association of deregulated protein chaperone pathway and the prospect of small molecule modulators of natural origin with therapeutic prospect.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- AD:
-
Alzheimer’s disease
- ALS:
-
Amyotrophic lateral sclerosis
- GFP:
-
Green fluorescent protein
- HD:
-
Huntington’s disease
- HSE:
-
Heat shock element
- HSF1:
-
Heat shock factor 1
- HSPs:
-
Heat shock proteins
- HSR:
-
Heat shock response
- MJD:
-
Machado-Joseph disease
- PD:
-
Parkinson’s disease
- PTM:
-
Posttranslational modifications
- SMBA:
-
Spinal and bulbar muscular atrophy
References
Abner EL, Jicha GA, Shaw LM et al (2016) Plasma neuronal exosomal levels of Alzheimer’s disease biomarkers in normal aging. Ann Clin Transl Neurol 3(5):399–403. https://doi.org/10.1002/acn3.309
Allison AC, Cacabelos R, Lombardi VR et al (2001) Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer’s disease. Prog Neuro-Psychopharmacol Biol Psychiatry 25(7):1341–1357. https://doi.org/10.1016/s0278-5846(01)00192-0
Anckar J, Sistonen L (2011) Regulation of HSF1 function in the heat stress response: implications in aging and disease. Annu Rev Biochem 80:1089–1115. https://doi.org/10.1146/annurev-biochem-060809-095203
Auluck PK, Chan HY, Trojanowski JQ et al (2002) Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson’s disease. Science 295(5556):865–868. https://doi.org/10.1126/science.1067389
Bastianetto S, Menard C, Quirion R (2015) Neuroprotective action of resveratrol. Biochim Biophys Acta 1852(6):1195–1201. https://doi.org/10.1016/j.bbadis.2014.09.011
Batulan Z, Shinder GA, Minotti S et al (2003) High threshold for induction of the stress response in motor neurons is associated with failure to activate HSF1. J Neurosci 23(13):5789–5798
Borra MT, Smith BC, Denu JM (2005) Mechanism of human SIRT1 activation by resveratrol. J Biol Chem 280(17):17187–17195. https://doi.org/10.1074/jbc.M501250200
Braga TM, Rocha L, Chung TY et al (2020) Biological activities of Gedunin-A Limonoid from the meliaceae family. Molecules (Basel, Switzerland) 25(3):493. https://doi.org/10.3390/molecules25030493
Brandt GE, Schmidt MD, Prisinzano TE et al (2008) Gedunin, a novel hsp90 inhibitor: semisynthesis of derivatives and preliminary structure-activity relationships. J Med Chem 51(20):6495–6502. https://doi.org/10.1021/jm8007486
Chen G, Zhang X, Zhao M et al (2011) Celastrol targets mitochondrial respiratory chain complex I to induce reactive oxygen species-dependent cytotoxicity in tumor cells. BMC Cancer 11(1):170. https://doi.org/10.1186/1471-2407-11-170
Chen Y, Wang B, Liu D et al (2014) Hsp90 chaperone inhibitor 17-AAG attenuates Abeta-induced synaptic toxicity and memory impairment. J Neurosci 34(7):2464–2470. https://doi.org/10.1523/jneurosci.0151-13.2014
Cleren C, Calingasan NY, Chen J et al (2005) Celastrol protects against MPTP- and 3-nitropropionic acid-induced neurotoxicity. J Neurochem 94(4):995–1004. https://doi.org/10.1111/j.1471-4159.2005.03253.x
Dobson CM (2003) Protein folding and misfolding. Nature 426(6968):884–890. https://doi.org/10.1038/nature02261
Gan N, Wu YC, Brunet M et al (2010) Sulforaphane activates heat shock response and enhances proteasome activity through up-regulation of Hsp27. J Biol Chem 285(46):35528–35536. https://doi.org/10.1074/jbc.M110.152686
Ghosh K, De S, Das S et al (2016) Withaferin A induces ROS-mediated paraptosis in human breast cancer cell-lines MCF-7 and MDA-MB-231. PLoS One 11(12):e0168488. https://doi.org/10.1371/journal.pone.0168488
Gomez-Pastor R, Burchfiel ET, Thiele DJ (2018) Regulation of heat shock transcription factors and their roles in physiology and disease. Nat Rev Mol Cell Biol 19(1):4–19. https://doi.org/10.1038/nrm.2017.73
Hamaguchi T, Ono K, Yamada M (2010) REVIEW: curcumin and Alzheimer’s disease. CNS Neurosci Ther 16(5):285–297. https://doi.org/10.1111/j.1755-5949.2010.00147.x
Jarrett JT, Lansbury PT Jr (1993) Seeding “one-dimensional crystallization” of amyloid: a pathogenic mechanism in Alzheimer’s disease and scrapie? Cell 73(6):1055–1058. https://doi.org/10.1016/0092-8674(93)90635-4
Jee H (2016) Size dependent classification of heat shock proteins: a mini-review. J Exerc Rehabil 12(4):255–259. https://doi.org/10.12965/jer.1632642.321
Jha SK, Dhar D, Krishnamoorthy G et al (2009) Continuous dissolution of structure during the unfolding of a small protein. Proc Natl Acad Sci U S A 106(27):11113–11118. https://doi.org/10.1073/pnas.0812564106
Jiang YQ, Wang XL, Cao XH et al (2013) Increased heat shock transcription factor 1 in the cerebellum reverses the deficiency of Purkinje cells in Alzheimer’s disease. Brain Res 1519:105–111. https://doi.org/10.1016/j.brainres.2013.04.059
Jimenez-Sanchez M, Licitra F, Underwood BR et al (2017) Huntington’s disease: mechanisms of pathogenesis and therapeutic strategies. Cold Spring Harb Perspect Med 7(7):a024240. https://doi.org/10.1101/cshperspect.a024240
Kim S, Nollen EA, Kitagawa K et al (2002) Polyglutamine protein aggregates are dynamic. Nat Cell Biol 4(10):826–831. https://doi.org/10.1038/ncb863
Kim SY, Lee HJ, Nam JW et al (2015) Coniferyl aldehyde reduces radiation damage through increased protein stability of heat shock transcriptional factor 1 by phosphorylation. Int J Radiat Oncol Biol Phys 91(4):807–816. https://doi.org/10.1016/j.ijrobp.2014.11.031
Kim E, Wang B, Sastry N et al (2016) NEDD4-mediated HSF1 degradation underlies alpha-synucleinopathy. Hum Mol Genet 25(2):211–222. https://doi.org/10.1093/hmg/ddv445
Krobitsch S, Lindquist S (2000) Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins. Proc Natl Acad Sci U S A 97(4):1589–1594. https://doi.org/10.1073/pnas.97.4.1589
Kroeger PE, Morimoto RI (1994) Selection of new HSF1 and HSF2 DNA-binding sites reveals difference in trimer cooperativity. Mol Cell Biol 14(11):7592–7603. https://doi.org/10.1128/mcb.14.11.7592
Kuiper EF, de Mattos EP, Jardim LB et al (2017) Chaperones in polyglutamine aggregation: beyond the Q-stretch. Front Neurosci 11:145. https://doi.org/10.3389/fnins.2017.00145
Li D, Shao R, Wang N, et al (2020) Sulforaphane activates a lysosome-dependent transcriptional program to mitigate oxidative stress. Autophagy 1–16. https://doi.org/10.1080/15548627.2020.1739442
Lin PY, Simon SM, Koh WK et al (2013) Heat shock factor 1 over-expression protects against exposure of hydrophobic residues on mutant SOD1 and early mortality in a mouse model of amyotrophic lateral sclerosis. Mol Neurodegener 8:43. https://doi.org/10.1186/1750-1326-8-43
Longinetti E, Mariosa D, Larsson H et al (2017) Physical and cognitive fitness in young adulthood and risk of amyotrophic lateral sclerosis at an early age. Eur J Neurol 24(1):137–142. https://doi.org/10.1111/ene.13165
Marathe SA, Dasgupta I, Gnanadhas DP et al (2011) Multifaceted roles of curcumin: two sides of a coin! Expert Opin Biol Ther 11(11):1485–1499. https://doi.org/10.1517/14712598.2011.623124
Misra S, Verma M, Mishra SK et al (2011) Gedunin and photogedunin of Xylocarpus granatum possess antifilarial activity against human lymphatic filarial parasite Brugia malayi in experimental rodent host. Parasitol Res 109(5):1351–1360. https://doi.org/10.1007/s00436-011-2380-x
Murphy MP, LeVine H 3rd (2010) Alzheimer’s disease and the amyloid-beta peptide. J Alzheimers Dis 19(1):311–323. https://doi.org/10.3233/jad-2010-1221
Nelson VK, Ali A, Dutta N et al (2016) Azadiradione ameliorates polyglutamine expansion disease in Drosophila by potentiating DNA binding activity of heat shock factor 1. Oncotarget 7(48):78281–78296. https://doi.org/10.18632/oncotarget.12930
Pangeni R, Sahni JK, Ali J et al (2014) Resveratrol: review on therapeutic potential and recent advances in drug delivery. Expert Opin Drug Deliv 11(8):1285–1298. https://doi.org/10.1517/17425247.2014.919253
Patwardhan CA, Fauq A, Peterson LB et al (2013) Gedunin inactivates the co-chaperone p23 protein causing cancer cell death by apoptosis. J Biol Chem 288(10):7313–7325. https://doi.org/10.1074/jbc.M112.427328
Putics A, Vegh EM, Csermely P et al (2008) Resveratrol induces the heat-shock response and protects human cells from severe heat stress. Antioxid Redox Signal 10(1):65–75. https://doi.org/10.1089/ars.2007.1866
Ross CA, Poirier MA (2004) Protein aggregation and neurodegenerative disease. Nat Med 10(Suppl):S10–S17. https://doi.org/10.1038/nm1066
Salehi B, Stojanovic-Radic Z, Matejic J et al (2019) The therapeutic potential of curcumin: a review of clinical trials. Eur J Med Chem 163:527–545. https://doi.org/10.1016/j.ejmech.2018.12.016
Santagata S, Xu YM, Wijeratne EM et al (2012) Using the heat-shock response to discover anticancer compounds that target protein homeostasis. ACS Chem Biol 7(2):340–349. https://doi.org/10.1021/cb200353m
Shi Y, Mosser DD, Morimoto RI (1998) Molecular chaperones as HSF1-specific transcriptional repressors. Genes Dev 12(5):654–666. https://doi.org/10.1101/gad.12.5.654
Singh BK, Vatsa N, Nelson VK et al (2018) Azadiradione restores protein quality control and ameliorates the disease pathogenesis in a mouse model of Huntington’s disease. Mol Neurobiol 55(8):6337–6346. https://doi.org/10.1007/s12035-017-0853-3
Soares TR, Reis SD, Pinho BR et al (2019) Targeting the proteostasis network in Huntington’s disease. Ageing Res Rev 49:92–103. https://doi.org/10.1016/j.arr.2018.11.006
Stefanis L (2012) α-synuclein in Parkinson’s disease. Cold Spring Harb Perspect Med 2(2):a009399. https://doi.org/10.1101/cshperspect.a009399
Subapriya R, Nagini S (2005) Medicinal properties of neem leaves: a review. Curr Med Chem Anticancer Agents 5(2):149–146
Teiten MH, Reuter S, Schmucker S et al (2009) Induction of heat shock response by curcumin in human leukemia cells. Cancer Lett 279(2):145–154. https://doi.org/10.1016/j.canlet.2009.01.031
Westerheide SD, Morimoto RI (2005) Heat shock response modulators as therapeutic tools for diseases of protein conformation. J Biol Chem 280(39):33097–33100. https://doi.org/10.1074/jbc.R500010200
Westerheide SD, Bosman JD, Mbadugha BN et al (2004) Celastrols as inducers of the heat shock response and cytoprotection. J Biol Chem 279(53):56053–56060. https://doi.org/10.1074/jbc.M409267200
Yu Y, Hamza A, Zhang T et al (2010) Withaferin A targets heat shock protein 90 in pancreatic cancer cells. Biochem Pharmacol 79(4):542–551. https://doi.org/10.1016/j.bcp.2009.09.017
Zhang Y, Kensler TW, Cho CG et al (1994) Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proc Natl Acad Sci U S A 91(8):3147–3150. https://doi.org/10.1073/pnas.91.8.3147
Zhang T, Hamza A, Cao X et al (2008) A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells. Mol Cancer Ther 7(1):162–170. https://doi.org/10.1158/1535-7163.Mct-07-0484
Zhang X, Timmermann B, Samadi AK et al (2012) Withaferin a induces proteasome-dependent degradation of breast cancer susceptibility gene 1 and heat shock factor 1 proteins in breast cancer cells. ISRN Biochem 2012:707586. https://doi.org/10.5402/2012/707586
Zhang J, Zhang R, Zhan Z et al (2017) Beneficial effects of sulforaphane treatment in Alzheimer’s disease may be mediated through reduced HDAC1/3 and increased P75NTR expression. Front Aging Neurosci 9:121–121. https://doi.org/10.3389/fnagi.2017.00121
Zoghbi HY, Orr HT (2000) Glutamine repeats and neurodegeneration. Annu Rev Neurosci 23:217–247. https://doi.org/10.1146/annurev.neuro.23.1.217
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Dutta, N., Ghosh, S., Pal, M. (2021). Neurodegenerative Diseases and Small Molecule Protein Chaperone Activator of Natural Origin. In: Mandal, S.C., Chakraborty, R., Sen, S. (eds) Evidence Based Validation of Traditional Medicines. Springer, Singapore. https://doi.org/10.1007/978-981-15-8127-4_5
Download citation
DOI: https://doi.org/10.1007/978-981-15-8127-4_5
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-8126-7
Online ISBN: 978-981-15-8127-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)